Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Unknown 1Terminated 1

Sponsor Class

OTHER 166NIH 19OTHER_GOV 4INDUSTRY 4FED 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 2Pancreatic Neoplasms 1Nervous System Diseases 1Metabolic Diseases 1Breast Neoplasms 1Aneurysm 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Magnetic Resonance Imaging × Clear all
NCT05191940 2026-03-20

LAPC

EBG MedAustron GmbH

Phase NA Recruiting
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04875871 2025-05-11

PARTICLE-PATHY

EBG MedAustron GmbH

Phase NA Terminated
13 enrolled
Tumor-Agnostic

Neoplasms

NCT06212479 2025-04-30

Hercules

Hercules

Recruiting
100,000 enrolled

Aneurysm, Metabolic Diseases, Neoplasms, Nervous System Diseases

NCT02209389 2014-08-19

OctavaPink for Women With Dense Breast After Negative Mammography

Eventus Diagnostics Ltd

Unknown
1,750 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡